Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sergey Bondarenko
Institution:
First Pavlov State Medical University of St. Petersburg
Observed institution:
First Pavlov State Medical University of St. Petersburg
ORCID:
0000-0002-2446-8092
Observed ORCID:
0000-0002-2446-8092
OpenAlex ID:
A5108806040
A randomized, multicenter phase II trial to compare prophylaxis of graft versus host disease with tacrolimus and mycophenolate mofetil versus ruxolitinib after post-transplant cyclophosphamide
2026
·
I Moiseev
, Mikhail Drokov
, et al.
·
Transplantation and Cellular Therapy
·
8
Long-term follow-up of predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia in the phase 3 COMMODORE trial
2026
·
Bin Jiang
, Jian Li
, et al.
·
Annals of Hematology
·
2
PDF
Correction to: Long-term follow-up of predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia in the phase 3 COMMODORE trial
2026
·
Bin Jiang
, Jian Li
, et al.
·
Annals of Hematology
·
1
PDF
Gilteritinib monotherapy and gilteritinib-based combination regimens in patients with relapsed or refractory FLT3-mutated acute myeloid leukemia
2026
·
Anna Smirnova
, Sergey Bondarenko
, et al.
·
Cellular Therapy and Transplantation
Allogeneic stem cell transplantation in first remission for FLT3-mutated acute myeloid leukemia
2026
·
Nikita Pastukhov
, Sergey Bondarenko
, et al.
·
Cellular Therapy and Transplantation
Cytokine release syndrome in adults with acute leukemia after allo-HCT with posttransplant cyclophosphamide prophylaxis
2026
·
Nikita Volkov
, Ivan Moiseev
, et al.
·
International Journal of Hematology
Timing of response in patients with relapsed/refractory FLT3mut+ acute myeloid leukemia treated with gilteritinib
2026
·
Alexander E. Perl
, Mark J. Levis
, et al.
·
Blood Neoplasia
PDF
ALL-277 Chemotherapy De-Escalation Does Not Alter the Effectiveness of Therapy for Ph+ Acute Lymphocytic Leukemia in the Era of Tyrosine Kinase Inhibitors
2024
·
Olga Aleshina
, Ekatreina Kotova
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Chemotherapy De-Escalation Does Not Alter the Effectiveness of Therapy for Ph+ Acute Lymphocytic Leukemia in the Era of Tyrosine Kinase Inhibitors
2024
·
Olga Aleshina
, Ekatreina Kotova
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
9
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type